FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2590515186> ?p ?o ?g. }

• W2590515186 endingPage "122" @default.
• W2590515186 startingPage "122" @default.
• W2590515186 abstract "122 Background: In gastric cancer, platinum and fluorouracil combination chemotherapy (CTx) is commonly used. But the optimal duration of CTx in palliative setting is not known. Thus, we reviewed the pts who rested CTx despite of persistent disease control. Methods: From Mar 2007 to Feb 2012 at Seoul St. Mary’s hospital, we retrospectively reviewed pts as follows; (1) had metastatic or recurrent gastric cancer, (2) received 9 cycles of FOLFOX as 1 st -line, (3) had no progressive disease (PD) and rested after completion of 9 th cycle. Results: Total 25 pts were reviewed. Median age was 54 (36~77) and 15 pts (60%) were male. 13 pts (52%) had recurrent disease and 12 metastatic initially. All pts were treated with oxaliplatin 100 mg/m 2 , leucovorin 400 mg/m2 on day 1 and 5-FU 1200 mg/m 2 on day 1-2 every 2 weeks. All pts had metastasis; carcinomatosis peritonei (CP, 56%), lymph node (36%), liver (20%) and bone (8%). Nine pts (48%) had non-measurable lesions and 3 no evidence of disease (NED) on CT after palliative surgery. Response evaluation was done every 3 cycles. Among 22 pts with evaluable disease, 5 (20%) showed complete response (CR), 8 (32%) partial response (PR), 2 (8%) stable disease (SD) and 7 (28%) non-CR/non-PD as best response. Median progression free survival (PFS) was 14.2 m (95% CI, 6.6-21.9). The PFS in CP vs. non-CP was 9.9 vs. 21.5 m (log rank P = .037). And PFS according to best response were as follows; 25.5 m in CR + NED group, 15.7 PR, 13.4 non-CR/non-PD and 4.3 SD (log rank P = .014). Other factors did not seem to affect PFS. Conclusions: This study suggested that resting CTx in selected pts would be reasonable in gastric cancer. Especially the presence of CP and the grade of response seemed to be important in patient selection." @default.
• W2590515186 created "2017-03-03" @default.
• W2590515186 creator A5014474281 @default.
• W2590515186 creator A5048033504 @default.
• W2590515186 creator A5064153008 @default.
• W2590515186 creator A5075108989 @default.
• W2590515186 creator A5083661343 @default.
• W2590515186 creator A5088316493 @default.
• W2590515186 date "2013-02-01" @default.
• W2590515186 modified "2023-09-26" @default.
• W2590515186 title "Resting palliative chemotherapy in patients with gastric cancer." @default.
• W2590515186 doi "https://doi.org/10.1200/jco.2013.31.4_suppl.122" @default.
• W2590515186 hasPublicationYear "2013" @default.
• W2590515186 type Work @default.
• W2590515186 sameAs 2590515186 @default.
• W2590515186 citedByCount "0" @default.
• W2590515186 crossrefType "journal-article" @default.
• W2590515186 hasAuthorship W2590515186A5014474281 @default.
• W2590515186 hasAuthorship W2590515186A5048033504 @default.
• W2590515186 hasAuthorship W2590515186A5064153008 @default.
• W2590515186 hasAuthorship W2590515186A5075108989 @default.
• W2590515186 hasAuthorship W2590515186A5083661343 @default.
• W2590515186 hasAuthorship W2590515186A5088316493 @default.
• W2590515186 hasConcept C121608353 @default.
• W2590515186 hasConcept C126322002 @default.
• W2590515186 hasConcept C141071460 @default.
• W2590515186 hasConcept C143998085 @default.
• W2590515186 hasConcept C2776694085 @default.
• W2590515186 hasConcept C2778260052 @default.
• W2590515186 hasConcept C2778822529 @default.
• W2590515186 hasConcept C2780962732 @default.
• W2590515186 hasConcept C526805850 @default.
• W2590515186 hasConcept C71924100 @default.
• W2590515186 hasConcept C90924648 @default.
• W2590515186 hasConceptScore W2590515186C121608353 @default.
• W2590515186 hasConceptScore W2590515186C126322002 @default.
• W2590515186 hasConceptScore W2590515186C141071460 @default.
• W2590515186 hasConceptScore W2590515186C143998085 @default.
• W2590515186 hasConceptScore W2590515186C2776694085 @default.
• W2590515186 hasConceptScore W2590515186C2778260052 @default.
• W2590515186 hasConceptScore W2590515186C2778822529 @default.
• W2590515186 hasConceptScore W2590515186C2780962732 @default.
• W2590515186 hasConceptScore W2590515186C526805850 @default.
• W2590515186 hasConceptScore W2590515186C71924100 @default.
• W2590515186 hasConceptScore W2590515186C90924648 @default.
• W2590515186 hasIssue "4_suppl" @default.
• W2590515186 hasLocation W25905151861 @default.
• W2590515186 hasOpenAccess W2590515186 @default.
• W2590515186 hasPrimaryLocation W25905151861 @default.
• W2590515186 hasRelatedWork W2098292062 @default.
• W2590515186 hasRelatedWork W2362472825 @default.
• W2590515186 hasRelatedWork W2389357660 @default.
• W2590515186 hasRelatedWork W2391741920 @default.
• W2590515186 hasRelatedWork W2409507836 @default.
• W2590515186 hasRelatedWork W2417717847 @default.
• W2590515186 hasRelatedWork W2739614678 @default.
• W2590515186 hasRelatedWork W2808934676 @default.
• W2590515186 hasRelatedWork W3041018076 @default.
• W2590515186 hasRelatedWork W3180214159 @default.
• W2590515186 hasVolume "31" @default.
• W2590515186 isParatext "false" @default.
• W2590515186 isRetracted "false" @default.
• W2590515186 magId "2590515186" @default.
• W2590515186 workType "article" @default.